KELSEY COCHRAN: Open Payments
NPI 1497459499 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,399 in 94 payments from 21 companies in 2025. Trend: 2023 $184 · 2024 $645 · 2025 $1,399
Food & beverage: $1,399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 27 | $221 |
| Lilly USA, LLC | 11 | $200 |
| Radius Health, Inc. | 17 | $185 |
| Medtronic, Inc. | 9 | $174 |
| Dexcom, Inc. | 3 | $98 |
| Tandem Diabetes Care, Inc. | 3 | $72 |
| Corcept Therapeutics | 3 | $71 |
| BETA BIONICS, INC. | 5 | $71 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $39 |
Products named: Tymlos, MINIMED 780G, Rybelsus, JARDIANCE, Dexcom G6 Transmitter, Ozempic, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across FL — which companies pay providers there.
